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Adequate knowledge and personal attitudes towards DNA-testing are major determinants of
optimal utilization of genetic testing. This study aims to (1) assess the genetic knowledge and
attitude towards genetic testing of patients with asthma, diabetes mellitus type II and cardio-
vascular diseases, (2) determine whether their knowledge or attitude changed since 2002, and
(3) investigate the predictive role of knowledge on attitude. Data were collected within the
Panel of Patients with Chronic Diseases in 2002 and 2004, resulting in 398 data-pairs. Results
show that factual knowledge mainly relates to associations between genes and diseases, less
is known on associations between genes, chromosomes, cells and body. The perceived knowl-
edge on DNA-testing has not increased since 2002. The attitude towards genetic testing also
appeared to be rather consistent. Less perceived medical genetic knowledge and more per-
ceived social genetic knowledge were found predictive for a more reserved attitude towards
genetic testing. In conclusion, advanced developments in the field of genetics are not accom-
panied by increased knowledge of patients with common multi-factorial diseases. The finding
that more perceived social genetic knowledge results in more reluctance can be considered
an indicator for the necessity of social debates on genetic testing.
KEY WORDS: genetic knowledge; attitudes; longitudinal; asthma; diabetes mellitus; cardiovascular dis-
eases; genetic counseling; genetic testing.
INTRODUCTION
Scientific knowledge in the field of medical
genetics is growing fast. The completion of the
Human Genome project in 2003, and the eventual
identification of thousands of human genetic vari-
ants, have heightened the expectations of health ben-
efits (Khouri et al., 2004). This rapidly accumulat-
ing knowledge will generate many possibilities for
health care and is expected to improve the quality
of life of individuals and families (Henneman et al.,
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2004). DNA tests become more and more available;
at the moment for hundreds of hereditary diseases
(Oosterwijk and Ausems, 2005). Until recently, sci-
entific and public attention was mainly directed at
monogenetic diseases, such as Huntington disease
(Leschot and Willems, 2004). However, there is
growing insight that genes also play a role in the de-
velopment of more common diseases, like asthma
or diabetes. The development or the seriousness of
a disease is then influenced by the environment in
which the genetic components are exposed; a person
with a genetic defect will thus be more sensitive to
certain environmental factors, e.g. nutritional factors
(Leschot and Willems, 2004).
Several chronic diseases are already known to
have a genetic component. Asthma, diabetes melli-
tus and cardiovascular diseases are highly prevalent
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examples of chronic diseases of which it is assumed
that both genetic and environmental factors are in-
volved in the development of the disease. Research
is taking place at this moment to determine what spe-
cific genes play a role in the development of asthma
(Leschot and Willems, 2004; Thakkinstian et al.,
2005). Diabetes mellitus is distinguished in two types,
Insulin Dependent Diabetes Mellitus (type 1), in par-
ticular prevalent in children and young adults, and
Non-Insulin Dependent Diabetes Mellitus (type 2),
in particular prevalent in older adults and often ac-
companied by obesity. The genetic predisposition in
the cause of diabetes mellitus still becomes clearer,
especially regarding type 2 diabetes, while environ-
mental factors, such as physical inactivity and adi-
posity mainly seem to play a role in the tempo of the
disease’s development (Illig et al., 2005; Kavvoura
and Ioannidis, 2005; Leschot and Brunner, 1998).
Regarding cardiovascular diseases, the most com-
mon cause of death in the developed world, it is now
well established that both genetic and environmental
factors influence the development of several cardio-
vascular disorders and its risk factors, such as hyper-
tension, particular fatty acids and obesity (Hall, 2005;
Iliadou and Snieder, 2004; Leschot and Willems,
2004).
Adequate knowledge regarding the genetic
component of diseases, as well as personal attitudes
towards DNA-testing, are major determinants of op-
timal utilization of genetic testing (Capelli et al., 1999;
Hietala et al., 1995). Several population studies, e.g.
in the Finnish and Dutch populations (Henneman
et al., 2004; Jallinoja and Aro, 1999), generally show a
lack of understanding of genes and heredity. Because
of the significance to chronically ill, to themselves
as well as to their families and offspring, Morren
and colleagues (in press) examined perceived knowl-
edge in chronically ill patients and their attitudes to-
wards DNA-testing. Their results also showed low
levels of perceived knowledge, especially in older
and lower educated chronic patients. Attitudes to-
wards genetic testing, on the other hand, were found
to be generally favorable, mostly in younger and
higher educated patients. Higher levels of perceived
knowledge were associated with more favorable
attitudes.
As the developments in genetic research are be-
lieved to be accompanied by due media attention, it
was decided to follow the patients with asthma, di-
abetes mellitus type 2, and cardiovascular disease,
who participated in the study of Morren et al. This
resulted in a repeated measurement two years later,
in 2004. Additionally, in order to help interpret the
level of genetic knowledge, a factual knowledge-
scale on genes and heredity was added to the sur-
vey. Our first aim is to contribute to current insights
into the genetic knowledge of patients with com-
mon multi-factorial diseases, and into the relation-
ship between genetic knowledge and attitudes to-
wards genetic testing. We furthermore aim to reveal
developments in perceived knowledge and attitudes
over a period of two years, as media attention goes
hand in hand with developments in genetic science.
For these purposes, we investigated whether patients
with asthma, type 2 diabetes and cardiovascular dis-
ease differ in their genetic knowledge or in their atti-
tude towards genetic testing. In addition, we looked
at the degree to which patients consider their ill-
ness as hereditary, and whether this would explain
the variation in genetic knowledge and attitudes to-
wards genetic testing. Finally, we examined whether
patients’ perceived knowledge and attitudes changed
over a period of two years, and whether perceived
knowledge can be considered predictive for the ge-




Patients were selected from the Panel of Pa-
tients with Chronic Diseases, a nationwide longitu-
dinal study on medically diagnosed chronically ill,
conducted in the Netherlands since 1998 (Rijken and
Bensing, 2000). All diagnoses were registered by the
general practitioners of the patients. For this study,
all patients with asthma, diabetes mellitus type 2
(DM), and several cardiovascular diseases (CVD)
were selected from the Panel on the basis of the pa-
tient’s first diagnosis according to the following codes
of the International Classification of Primary Care
(Lamberts and Wood, 1987): R96 (asthma), T90.2
(diabetes mellitus type 2), and K74, K75, K76, K87,
K90, and K91 (cardiovascular disease). The first sur-
vey was held in April 2002, in which 577 patients re-
sponded: 299 patients with asthma, 144 with diabetes
mellitus type 2, and 134 with cardiovascular disease
(response 79.1%, 82.3%, and 80.2% respectively).
The survey was repeated in April 2004. From the
2002-group, 113 patients could not be approached
because of death (n = 13), health-related reasons
(n = 9), admission in a nursing home (n = 3), or
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because they just wished to stop participating in the
Panel (n = 88). Thus, 464 patients could be ap-
proached, of whom 398 patients responded: 206 pa-
tients with asthma, 102 patients with diabetes melli-
tus type 2, and 90 patients with cardiovascular disease
(response 83.7%, 87.9%, and 88.2% respectively).
Non-respondents were reminded twice to obtain as
many respondents as possible.
Before patients enrolled in our panel, their in-
formed consent was obtained. The Panel of Patients
with Chronic Diseases is registered with the Dutch
Data Protection Authority. The data were collected
according to the privacy protection guidelines of this
Authority.
Measurement
Data were gathered using a postal survey. No
information on genetics was given in the cover let-
ter, nor in the questionnaire’s introduction. Apart
from gender, age, and educational level as socio-
demographic characteristics, illness duration and co-
morbidity (number of chronic physical diseases)
were assessed. Data on these disease related char-
acteristics were collected via general practitioners,
after permission of the patients, at the moment of
enrolment in the panel. Illness duration reflects the
number of years since the first chronic illness (in this
study asthma, diabetes type 2 or cardiovascular dis-
ease) was diagnosed. Only for presenting frequency
distributions, educational level was classified into a
basic level (no, primary, or lower vocational educa-
tion), an intermediate level (secondary or interme-
diate vocational education), and a high level (higher
vocational education or university).
Factual knowledge was assessed in the survey of
April 2004. It was measured by means of 16 struc-
tured items on genes and heredity in general. These
items were derived from Jallinoja and Aro (1999)
and translated into Dutch. The items measure the
knowledge about the association of genes and dis-
eases and the association of genes, chromosomes,
cells and the body. According to Jallinoja and Aro,
a summary index of the correct answers was formed
(score 1 correct, score 0 incorrect/don’t know). If
some items were not completed (‘user missing’) but
other items were answered, user missings were re-
placed by “don’t know” (thus scored as a 0). Only
when the total question of 16 items was missed, the
case was excluded from analyses. This resulted in 306
valid and 92 missing cases. The reliability of this sum-
mary index was found equal to Jallinoja and Aro
(Cronbach’s alpha 0.86).
Perceived knowledge of genetics was measured
by means of 11 items about the possibilities and con-
sequences of DNA-testing, in April 2002 as well as
in April 2004. Items were selected to cover major is-
sues in relevant literature (Morren et al., in press).
Respondents indicated whether they had knowledge
about every item on a 3-point scale (0 = nothing,
1 = something, 2 = much). Because of slightly dif-
ferent answering categories for the scores (1) and (2)
in 2004, comparisons on item level are reported only
for the answering category (0) “I know nothing,” thus
reflecting possible changes in the proportion of pa-
tients who indicate to have no knowledge about that
particular subject. Following Morren et al., two scales
were created: knowledge about the medical possibil-
ities of genetic testing (5 items), e.g. “The possibility
to use genetic knowledge to prevent or treat a disor-
der,” and knowledge about the social consequences
of genetic testing (6 items), e.g. “The consequences
of DNA-testing for my work” (see Table IV). Pear-
son correlation between both scales was 0.67. Subse-
quently, total perceived genetic knowledge was com-
puted by means of a summary score of the total scale
(Cronbach’s alpha 0.91), with a range of 0–22. In
the same way summary scores were computed for the
two separate scales: perceived medical knowledge
(range 0–10) and perceived social knowledge (range
0–12). The reliability of both scales (Cronbach’s al-
pha) was 0.88 and 0.86 respectively. Test-retest relia-
bility (intraclass correlation coefficient) of the scales
was 0.66 (total), 0.68 (medical), and 0.60 (social).
Attitude towards genetics was examined by
means of 13 statements on genetic testing (see
Table VII), in 2002 and in 2004. These items were
also selected from the literature (Morren et al., in
press). Items were scored on a 5-point scale (1 = to-
tally disagree; 2 = disagree; 3 = don’t know;
4 = agree; 5 = totally agree). To facilitate inter-
pretation of the frequency distributions, the items
were recoded into three categories: ‘agree’ and ‘dis-
agree’ (combination of the original responses ‘to-
tally (dis)agree’ and ‘(dis)agree’) and ‘don’t know.’
Like Morren and colleagues, two scales were then
composed, measuring a favorable attitude (6 state-
ments on pros of genetic testing), e.g. “I approve of
using DNA-testing for early detection of diseases,”
and a reserved attitude (7 statements on cons of ge-
netic testing), e.g. “I worry about the consequences
of DNA-testing for the chances of finding a job” (see
Table VI). Both scales were computed by means of
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adding up the item scores, with favorable attitude
ranging from 6–30 (Cronbach’s alpha 0.82), and re-
served attitude ranging from 7–35 (Cronbach’s al-
pha 0.70). The intraclass correlation coefficient (re-
flecting test-retest reliability) was 0.66 in both scales.
As the scales measure two different concepts, hardly
correlating with each other (r = −0.18), they were
not added up to create one total genetic attitude
scale. This phenomenon of creating two independent
dimensions measuring a rather positive and a rather
negative attitude is supported by former research.
For example, Parisi and Katz (1986) constructed at-
titude scales to measure the public’s views towards
posthumous organ donation, which resulted in a re-
liable measurement of two independent dimensions,
namely prodonation and antidonation (r = .003).
Considering own disease as hereditary was as-
sessed by one item on a 7-point scale, from (1) not at
all genetic, to (7) totally genetic. Just for presenting
frequency distributions, the answers were regrouped
into three categories, representing hardly genetic,
half genetic, and mainly genetic. In the analyses we
used the original 7-point scale.
Statistics
Group differences in frequencies and mean
scores were examined by means of chi square tests, or
analyses of variance. In analyses of variance, Scheffe´
or Tamhane’s T2 were used for post hoc compar-
isons, dependent on the Test of Homogeneity of
Variances (Scheffe´ in case of equal variances).
To determine whether the three diagnostic
groups differ regarding factual genetic knowledge,
perceived genetic knowledge and attitude towards
genetic testing, multivariate analysis of variance was
applied. McNemar change tests and paired samples
t-tests were applied, for dichotomous and continu-
ous variables respectively, in order to assess signifi-
cant changes in perceived knowledge and genetic at-
titudes from April 2002 to April 2004.
To assess the association between considering
the illness as hereditary on the one hand, and fac-
tual knowledge, perceived knowledge (total, med-
ical and social) and attitude (favorable and re-
served) on the other hand, linear regression analyses
were performed using the enter-method. In these
regression models, socio-demographic variables as
age, gender and educational level were first entered
into the model. Next, disease related characteristics,
such as diagnosis (dummy’s), comorbidity and illness
duration were entered in a separate block, followed
by the variable ‘considering their illness as heredi-
tary.’ Finally, to assess the predictive value of per-
ceived knowledge to genetic attitudes, perceived
genetic knowledge in 2002, together with factual
genetic knowledge and attitude in 2002, was added
to the regression equation.
RESULTS
Characteristics of The Sample
Table I presents the socio-demographic and dis-
ease related characteristics of the sample. The three
diagnostic groups differed with regard to all mea-
sured background characteristics. The asthma and
CVD samples consist of more, respectively less fe-
male respondents compared to the DM group. Con-
cerning the age and educational distributions, the
asthma group is deviating from the other two sam-
ples, in the sense of younger and higher educated re-
spondents. With regard to illness duration, respon-
dents with asthma and DM had a shorter illness
history than CVD patients, generally. Furthermore,
asthma patients are less often characterized by co-
morbidity, whereas CVD respondents have more of-
ten comorbidity compared with DM patients. Finally,
more asthma patients reported to consider their ill-
ness as hereditary, compared to DM and CVD pa-
tients (Fig. 1). This difference, however, disappears
when the differences regarding socio-demographic
characteristics are taken into account.
The distribution of respondents among the di-
agnostic groups in 2002 and 2004 was equal to one
another with regard to the response. Only the age
distribution in the loss in follow up was found to
be different from that in the respondents in 2004,
with especially the older patients failing to partici-
pate for the second time. The composition of the loss
in follow-up was equal to that of the respondents with
regard to the other background characteristics (data
not shown).
Factual Genetic Knowledge
The best-known items of genes and heredity
relate to statements on the associations between
genes and diseases (Table II). For example, the state-
ment “The onset of certain diseases is due to genes,
environment and lifestyle” was correctly answered
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Table I. Socio-Demographic and Disease Characteristics of Patients with Asthma, Diabetes
Mellitus Type 2 (DM), and Cardiovascular Disease (CVD) Who Responded in Both Surveys,
in April 2002 and April 2004 (n = 398)
Asthma (n = 206) DM (n = 102) CVD (n = 90)
Gender (% female) 65.5 51.0 35,6 ∗
Age (%)
15–44 years 44.7 5.9 2,2
45–64 years 39.8 46.1 44.4
≥65 years 15.5 48.0 53.3
Mean (SD), range 16–86 47.4 (15.5) 63.8 (11.6) 65.8 (9.8) ∗
Educational level (%)
Basic 31.9 60.9 57.1
Intermediate 43.1 27.2 34.5
High 25.0 12.0 8.3
Mean (SD), range 1–8 4.8 (1.8) 3.7 (1.6) 3.7 (1.4) ∗
Illness duration (%)
0–5 years 28.0 55.2 35.7
5–10 25.3 31.3 35.7
>10 years 46.8 13.5 28.6
Mean (SD), range 1–64 2.9 (11.5) 6.4 (5.5) 8.1 (6.0) ∗
Comorbidity (number of chronic diseases, %)
One 81.1 75.5 50.0
Two 13.6 15.7 36.7
Three or more 5.3 8.8 13.3 ∗
Consider own illness as hereditary (%)
Hardly genetic 39.8 64.9 69.4
Half genetic 29.6 20.8 15.3
Mainly genetic 30.6 14.3 15.3
Mean (SD), range 1–7 3.5 (1.9) 2.5 (1.8) 2.4 (1.8) ∗
∗p < 0.05.
by more than 70% in all diagnostic groups. The
least-known items concern statements on associa-
tions among genes, chromosomes, cells and body, e.g.
“Genes are bigger than chromosomes” (correctly an-
swered by 30% or less).
At first sight, asthma patients show more fac-
tual genetic knowledge than patients with DM and
CVD (F(2) = 13.53, p < 0.000). However, this dif-



















Fig. 1. Distribution of patients with asthma, diabetes mellitus
type 2 (DM), and cardiovascular disease (CVD) considering their
illness as hereditary.
age, gender and educational level into account. Re-
gression analysis (Table III) revealed a younger age
and higher educational level, as well as the perceived
extent of heredity of the own illness, as important
factors for the level of factual knowledge. The to-
tal model, also including gender and disease related
characteristics, accounted for 41% of the variance
(AR2 measured 0.39).
Perceived Genetic Knowledge
Table IV shows the proportions of patients
with asthma, DM and CVD reporting to have no
knowledge on the several statements measuring the
medical possibilities and social consequences of ge-
netic testing in 2002 and 2004. Most patients re-
port to have no knowledge about the consequences
of DNA-testing in the social sphere, of which the
consequences of DNA-testing for work are least-
known. In 2004, these percentages vary between
78% in asthma patients and 89% in CVD patients.
With regard to medical possibilities, the least-known
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Table II. Factual Genetic Knowledge of Patients with Asthma, Diabetes Mellitus Type 2 (DM) and Cardiovascular Disease (CVD), in
2004 (% of respondents with a correct answer)
Patients with
Statement Asthma (n = 181) DM (n = 61) CVD (n = 64)
1. One can see a gene with the naked eye. (not correct) 87 71 73
2. Healthy parents can have a child with a hereditary disease. (correct) 84 79 66
3. The onset of certain diseases is due to genes, environment and lifestyle. (correct) 83 74 73
4. A gene is a disease. (not correct) 82 62 73
5. The carrier of a disease gene may be completely healthy. (correct) 79 69 55
6. All serious diseases are hereditary. (not correct) 72 62 47
7. A gene is a molecule that controls hereditary characteristics. (correct) 61 53 44
8. Genes are inside cells. (correct) 60 41 39
9. The child of a disease gene carrier is always also a carrier of the same disease
gene. (not correct)
56 36 33
10. A gene is a piece of DNA. (correct) 56 44 28
11. A gene is a cell. (not correct) 44 25 19
12. A gene is a part of a chromosome. (correct) 43 31 30
13. Different body parts include different genes. (not correct) 32 20 17
14. Genes are bigger than chromosomes. (not correct) 30 20 13
15. The genotype is not susceptible to human intervention. (correct) 17 21 11
16. It has been estimated that a person has about 30,000 genes. (correct)a 12 5 9
Total mean score (range 0–16) (SD) 9.0 (4.0) 7.1 (3.8) 6.3 (3.5)
aAt the time of the questionnaire, this estimation was correct. The number of genes is now estimated at 22,000.
subject relates to the possibilities and risks of gene
therapy, with percentages ‘having no knowledge’
varying from 61% in asthma patients to 74% in DM
patients in 2004. The best-known subject concerns
the possibility of early detection of certain disor-
ders using DNA-tests, with 20% of the patients with










Diagnosis DM (ref. asthma) 0.03
Diagnosis CVD (ref. asthma) −0.02
Illness duration −0.03
Comorbidity 0.01
Consider own illness as hereditary 0.13∗ ∗
F-value (df) 20.61 (8,234)∗∗∗
R2–adjusted 0.39
Note. DM: diabetes mellitus; CVD: cardiovascular disease.
p: Significance of the F change-statistic; ns: not significant.
aFinal betas and significance levels.
∗p < 0.05. ∗∗p < 0.01. ∗∗∗p < 0.001.
asthma to 36% of the patients with DM or CVD re-
porting to have no knowledge about this.
In general, the perceived genetic knowledge has
not increased over a period of two years. On the con-
trary, mean scores in asthma patients on the scale
total knowledge, as well as on the separate scales
are significantly lower in 2004 compared to 2002, in
particular with regard to the consequences of DNA-
testing for work and the rights of third parties to in-
quire about the results of a DNA-test.
The three diagnostic groups differ from each
other in their perceived genetic knowledge, with
asthma patients reporting more knowledge than
patients with DM or CVD. However, again, when
we take the composition differences into account,
this difference disappears. The same results emerged
when perceived medical knowledge and perceived
social knowledge were considered separately.
Table V shows the results of the multivariate re-
gression analyses of perceived genetic knowledge in
2004.
The regression model revealed educational level
as most important factor for perceived genetic
knowledge in 2004, especially with regard to knowl-
edge on medical possibilities of genetic testing. The
total model, however, only accounted for 9% and
14% of the variance, respectively (AR2 0.07 and
0.12). The perception of heredity of own illness only
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Table IV. Perceived Knowledge of Patients with Asthma, DM and CVD on Genetic Testing, in 2002 and 2004
Asthma DM CVD
% Reporting to have no knowledge 2002 2004 2002 2004 2002 2004
On medical field
The possibilities and risks of gene therapy 61 61 77 74 78 71
The significance of DNA-testing for my relatives 44 47 68 61 58 61
The significance of DNA-testing for my offspring 43 49 74 64 60 63
The possibility to use genetic knowledge to prevent or treat
a disorder
35 33 64 52 61 51
The possibility of early detection of certain disorders using
DNA-testing
20 20 46 36 39 36
Mean score on knowledge on medical field (range 0–10) (SD) 3.9 (3.0) 3.1∗ (2.3) 2.0 (2.7) 2.1 (2.0) 2.3 (2.5) 2.3 (2.3)
On social field
The consequences of DNA-testing for my work 71 78∗ 86 88 88 89
The consequences of DNA-testing for taking out insurance 68 73 83 80 82 82
The rights of third parties to inquire about the results of
a DNA-test
70 78∗ 85 86 83 80
The consequences of DNA-testing for my daily life 67 73 84 82 79 82
Your rights to refuse DNA-testing 68 66 82 74 75 75
Your own possibilities to apply for a DNA-test 64 68 83 67∗ 79 81
Mean score on knowledge on personal sphere (range 0–12) (SD) 2.5 (3.6) 1.8∗ (2.4) 1.1 (2.4) 1.3 (2.3) 1.3 (2.6) 1.1 (2.0)
Mean score on TOTAL perceived knowledge (range 0–22) (SD) 6.5 (6.2) 5.0∗ (4.3) 3.2 (4.7) 3.4 (3.9) 3.6 (4.6) 3.5 (4.0)
∗Change between 2002 and 2004, p < .05.
showed to be a small contributor to perceived medi-
cal genetic knowledge. The regression model did not
explain any variance of perceived knowledge on so-
cial consequences of genetic testing.
Attitudes Towards Genetic Testing
In all three diagnostic groups, the majority
agreed on several statements measuring a favorable
view towards DNA-testing, in 2002 as well as in 2004
(Table VI). Most positive were patients about the
more broadly formulated statements, e.g. ‘. . . hope-
ful for the treatment of diseases’ (78% to 86%) or
‘. . . early detection of diseases’ (76% to 85%). Most
opinions on specific statements did not change over a
period of two years. Looking at the total scale score,
both the asthma group and DM group scored lower
in 2004, reflecting a less favorable attitude towards
genetic testing. The diagnostic groups did not differ
Table V. Regression Analyses of Perceived Genetic Knowledge in 2004
Total knowledge Medical knowledge Social knowledge
Betaa p Betaa p Betaa p
Socio-demographic characteristics ∗∗∗ ∗∗∗ ns
Gender (ref. male) −0.03 0.01 −0.06
Age 0.01 −0.05 0.05
Educational level 0.19∗∗ 0.23∗∗∗ 0.12
Disease-related characteristics ns ns ns
Diagnosis DM (ref. asthma) −0.02 −0.02 −0.02
Diagnosis CVD (ref. asthma) −0.04 −0.02 −0.04
Illness duration 0.10 0.09 0.10
Comorbidity −0.02 0.01 −0.03
Consider own illness as hereditary 0.13 ns 0.15∗ ∗ 0.08 ns
F-value (df) 3.37 (8,263) ∗∗∗ 5.36 (8,256) ∗∗∗ 1,48 (8,260)
R2–adjusted 0.07 0.12 0.01
Note. DM: diabetes mellitus; CVD:cardiovascular disease.
p: Significance of the F change-statistic ns: not significant.
aFinal betas and significance levels.
∗p < 0.05. ∗∗p < 0.01. ∗∗∗p < 0.001.
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Table VI. Attitudes Towards Genetic Testing of Patients with Asthma, Diabetes Mellitus Type 2 (DM), and Cardiovascular Disease
(CVD), in 2002 and 2004
Asthma (n = 206) DM (n = 102) CVD (n = 90)
Favorable (% agree) 2002 2004 2002 2004 2002 2004
I think the development of DNA research is
hopeful for the treatment of diseases
86 86 83 78 79 81
I think that the development of DNA research is a
positive medical progress
85 82 82 79 77 84
I approve of using DNA-testing for early detection
of diseases
81 85 77 76 78 80
I would inform my siblings about the results of a
DNA-test for a specific disease
74 75 65 61 65 75
I would inform my children about the results of a
DNA-test for a specific disease
75 72 65 57 68 73
I want to know whether my disease is hereditary 70 56∗ 68 50 68 56
Mean score on favorable attitude (range 6–30) (SD) 24.0 (3.8) 23.5∗ (4.0) 23.9 (4.1) 22.8∗ (3.5) 24.4 (4.4) 23.9 (4.7)
Asthma DM CVD
Reserved (% agree) 2002 2004 2002 2004 2002 2004
The possibility of a DNA-test will change one’s
future
58 52 51 40∗ 43 44
I worry about the consequences of DNA-testing for
being able to take out insurance
50 51 55 46 46 37
As long as a disease cannot be treated, I don’t want
a DNA-test
41 40 46 39 55 41
If I had a DNA-test done, my family need not know
about the result
35 33 45 34∗ 36 22∗
I worry about the consequences of DNA-testing for
the chances of finding a job
35 31 30 30 30 28
I don’t want a DNA-test to tell me that I am at risk
for a certain disease
32 38 37 40 34 33
The idea of DNA-tests frightens me 26 25 28 28 26 21
Mean score on reserved attitude (range 7–35) (SD) 20.9 (4.9) 20.4 (4.7) 22.1 (4.3) 21.7 (4.7) 22.7 (5.0) 20.1∗ (5.0)
∗Change between 2002 and 2004, p < .05.
from each other with respect to a favorable attitude
towards genetic testing.
Concerning the rather reserved opinions on ge-
netic testing, a minority agreed on most items. Least
reserved are patients about the idea of DNA-tests,
although still 21% of the CVD-patients to 28% of
the DM-patients experience the idea of DNA-tests as
frightening. Also, relatively many patients indicated
to worry about the consequences of DNA-testing for
taking out insurances. Again, most views on these as-
pects of genetic testing were found to remain stable.
In 2004, less patients with DM and CVD reported
that in case of a DNA-test, their family need not to
know about the results. Furthermore, less patients
with DM think that the possibility of a DNA-test will
change one’s future, than they did in 2002. Looking
at the total scale score, the CVD group scored lower
in 2004, reflecting a less reserved attitude towards
genetic testing. The diagnostic groups did not differ
from each other with respect to a reserved attitude.
Table VII shows the results of two regression
models of a favorable and reserved attitude to-
wards genetic testing. Model A reflects the regres-
sion model assessing the association between consid-
ering the illness as hereditary on the one hand, and
attitude on the other hand, taking socio-demographic
and disease-related characteristics into account. Con-
sidering their own illness as hereditary appeared to
be positively related to a favorable attitude towards
genetic testing. A similar, but less significant relation-
ship was found for comorbidity.
In regression model B perceived genetic
knowledge was added in order to examine whether
perceived genetic knowledge can be considered pre-
dictive for the attitude towards genetic testing. These
analyses revealed a relationship between perceived
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Table VII. Regression Analyses of Favorable and Reserved Attitudes Towards Genetic Testing in 2004
Favorable attitude in 2004 Reserved attitude in 2004
Model A Model B Model A Model B
Betaa p Betaa p Betaa p Betaa p
Socio-demographic characteristics Ns ∗ ns ns
Gender (ref. male) 0.03 −0.01 0.01 0.10
Age 0.12 0.16 −0.06 0.02
Educational level 0.03 0.07 −0.14 −0.14
Disease-related characteristics ∗ ns ns ns
Diagnosis DM (ref. asthma) −0.05 0.01 0.05 −0.03
Diagnosis CVD (ref. asthma) 0.04 0.05 0.01 0.06
Illness duration 0.08 0.08 −0.05 −0.01
Comorbidity 0.16∗ 0.10 −0.10 −0.09
Consider own illness as hereditary 0.21∗∗ ∗∗∗ 0.11 ∗ −0.03 ns −0.10 ns
Attitude in 2002 ∗∗∗ ∗∗∗
Favorable attitude 0.44 ∗∗∗ —
Reserved attitude — 0.49 ∗∗∗
Genetic knowledge ns ∗∗
Factual knowledge (2004) −0.03 0.18 ∗
Perceived medical knowledge in 2002 − 0.02 −0.24 ∗
Perceived social knowledge in 2002 −0.03 0.28 ∗∗
F-value (df) 2.95 (8,248) ∗∗ 5.33 (12,163) 1.32 (8,240) ns 6.53 (12,156)
R2–adjusted 0.06 0.23 0.01 0.28
Note. DM: diabetes mellitus; CVD: cardiovascular disease.
p: Significance of the F change-statistic; ns: not significant.
aFinal betas and significance levels.
∗p < 0.05. ∗∗p < 0.01. ∗∗∗p < 0.001.
knowledge (in 2002) and a reserved attitude (in
2004): more perceived medical genetic knowledge
was found to be associated with a less reserved
attitude, whereas more social genetic knowledge was
found to be associated with a more reserved attitude.
Furthermore, a positive relationship was found
between factual knowledge and a reserved attitude.
The total model, also including socio-demographic
and disease related characteristics, and reserved
attitude in 2002 (which was the strongest predictor),
accounted for 33% of the variance (AR2 0.28).
Perceived knowledge did not predict a favorable
attitude.
DISCUSSION
Scientific knowledge on genetic testing is rapidly
increasing. This is not the case with the genetic
knowledge perceived by patients with highly preva-
lent chronic diseases that are known to be partially
caused by genetic defects. Our results show that
perceived knowledge on genetic testing has not in-
creased in patients with asthma, diabetes mellitus
type 2, and cardiovascular disease, in a period of two
years. On the contrary, with regard to specific sub-
jects, perceived knowledge of asthma patients even
decreased. According to Berth and colleagues (2002)
it is likely that the vast quantity of information about
new achievements and promises of gene technol-
ogy reported by the mass media leaves the public
in a state of confusion, resulting in misconceptions.
However, another possible explanation for our re-
sults is that, due to media attention, people learn
that scientific knowledge on genetics is rapidly in-
creasing, so that more attention in the media might
just cause people to realize more and more that their
own knowledge of genetics only comprises a small
part of what is known. Perceived genetic knowledge
was found to be associated with a higher educational
level, especially knowledge about the medical pos-
sibilities of genetic testing. This finding is in line
with our results on factual knowledge of genes and
heredity; our results also show a positive relation-
ship with a higher level of genetic knowledge. Apart
from the educational level, age was found to be asso-
ciated with factual knowledge, that is, a higher age
is related to a lower knowledge level. These find-
ings on age and educational level are consistent with
findings of other studies (e.g. Henneman et al, 2004;
Jallinoja and Aro, 1999). Possibly, elderly people are
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less likely to be influenced by the media. AAlterna-
tively, the younger subjects are more likely to have
studied biology and genetics in their schooling, re-
gardless of their level of education.
In addition, our results on factual knowledge
in patients with asthma, diabetes, and cardiovascu-
lar disease are in line with the results of Jallinoja
and Aro (1999) in the Finnish general population
with regard to the best-known and least-known sub-
jects. We also found the same distributions in socio-
demographic characteristics (data not shown). How-
ever, in our study relatively many respondents (23%)
skipped the complete question, which consisted of 16
items. This possibly indicates a low interest in genet-
ics, or may be the items were valuated as too diffi-
cult or ‘too far from my bed.’ Further analyses, in this
connection, show that only 12 respondents reported
to have actually applied for or attended a DNA- test
(data not shown). One can also take into consider-
ation that the frame of reference of the majority of
our sample is to treat the illness and the environment
so that they can get better, since they have already
been diagnosed. In addition, further analyses show
that the non-respondents on factual knowledge gen-
erally were older and had a lower educational level
(data not shown). Jallinoja and Aro also attribute
their moderate response to the topic of their ques-
tionnaire. As the so-called system-missings were not
taken into account in calculating the factual knowl-
edge score, our findings may be an overestimation of
the factual knowledge of genes and heredity.
Apart from the level of genetic knowledge and
possible shifts in two years time, we wished to in-
vestigate whether the three diagnostic groups dif-
fered from each other with regard to genetic knowl-
edge as well as to the attitude towards gene testing,
and whether these differences could be explained
by the extent of considering the illness as heredi-
tary. Taking the socio-demographic composition dif-
ferences among the diagnostic groups into account,
we did not find any differences between patients
with asthma, diabetes, and cardiovascular disease.
However, we did find positive relationships between
considering the own illness as hereditary on the
one hand, and factual knowledge, perceived medical
knowledge and favorable attitude on the other hand,
again, taking socio-demographic and disease related
characteristics into account. This means that the per-
ception of heredity of the own illness is of additional
value in studying genetic knowledge and attitude.
The attitude of patients with asthma, diabetes,
or cardiovascular disease towards genetic testing is
rather stable. The majority appeared to be in favor
of the medical possibilities of gene tests in general.
When it comes to more social consequences, such as
consequences for taking out insurances, patients are
more concerned. High approval on gene tests is also
found in the general public, as well as in specific sam-
ples at risk for genetic diseases (Berth et al., 2002;
Capelli et al., 2001; Hietala et al., 1995).
An interesting finding of our study is that a re-
served attitude appeared to be partly determined by
the level of perceived knowledge; more medical ge-
netic knowledge was found predictive for less reluc-
tance, whereas more social genetic knowledge results
in more reluctance. These results offer opportunities
for health educational programs on the one hand, but
at the same time, can be considered a signal for the
necessity of social debates on these possible conse-
quences. In other words, as adequate knowledge and
personal attitudes are major determinants of optimal
utilization of genetic testing, more attention to the in-
creasing medical possibilities should go hand in hand
with discussion on what this brings about regarding
daily life, work, or taking out insurances.
Study Limitations
We have to take into consideration, in the inter-
pretation of the results, that we lost relatively many
patients in the follow-up study, possibly causing a se-
lection of patients. This loss in follow-up can partly
be explained by the fact that patients with diabetes
and cardiovascular disease who participate in the
panel are requested to fill in and return a question-
naire twice a year, asthma patients even three times
a year. That means that three (or five) other ques-
tionnaires have been distributed among the panel
members between April 2002 and April 2004, which
can be considered a strenuous task. Furthermore, pa-
tients with chronic illnesses are characterized by a
high age, resulting in an even higher loss in follow
up because it takes too much effort to participate in
a study. On the other hand, the representativeness of
the Panel of Patients with Chronic Diseases can be
considered an important strength of this study. In re-
lation to the sample size, we did not determine effect-
sizes in advance of this study. The findings of the
first part of this study (carried out in 2002, Morren
et al., in press) were interesting in such a way that it
was decided to repeat the study two years later. We
therefore reported and discussed only statistically
significant effects. However, this does not mean that
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non-significant findings in our study are not worth-
while for further investigation. With our sample size
we were able to detect the effects as described. With
larger sample sizes possibly more effects could have
been found, on, for instance, the changes in knowl-
edge and attitude in two years. Yet, the period of
two years might be too short to detect these possible
changes.
Another consideration concerns the genetic-
related issues that we have measured, as genetic
knowledge comprises more issues than we could in-
clude in our questionnaire. We have tried to compen-
sate this limitation by combining perceived knowl-
edge with a factual knowledge-scale, in order to
facilitate the interpretation of the level of knowledge.
However, repeated measurement of factual knowl-
edge is also needed when monitoring changes in ge-
netic knowledge levels.
CONCLUSIONS
In conclusion, rapid developments in scientific
knowledge in the field of medical genetics are not ac-
companied by increased knowledge in patients with
asthma, diabetes mellitus type 2, and cardiovascu-
lar disease. Also, the attitudes towards DNA-testing
were rather stable over a period of two years. Genetic
knowledge and attitude of patients with chronic dis-
eases that are known to be partially genetic, seem to
be comparable to the knowledge and attitude of the
general public. However, study into genetic knowl-
edge and attitude towards genetic testing has shown
that the perception of heredity of the own illness can
be of additional value. Perceived knowledge of the
medical opportunities genetic testing can offer, was
found predictive for less reluctance towards DNA-
testing, which paves the way for health education
programs. On the other hand, the finding that more
perceived knowledge of social consequences results
in more reluctance can be considered an indicator for
the necessity of a social debate and the involvement
of patients when approaching these possible conse-
quences. For future research, it is important to con-
tinue monitoring perceived knowledge, as our find-
ings point out that perceived knowledge determines
the attitude of patients with asthma, diabetes, and
cardiovascular disease. However, without repeated
measurement of factual knowledge at the same time,
the interpretation of perceived knowledge levels re-
mains difficult.
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